
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 7.470 | 7.470 | 0.000 |
Shares | 93.450 | 93.450 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.478 | 18.341 |
Price to Book | 3.493 | 2.452 |
Price to Sales | 3.558 | 1.935 |
Price to Cash Flow | 14.515 | 11.671 |
Dividend Yield | 2.051 | 2.443 |
5 Years Earnings Growth | 9.209 | 12.540 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 89.680 | 8.490 |
Industrials | 5.440 | 22.395 |
Consumer Defensive | 4.880 | 9.517 |
Number of long holdings: 25
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Zhejiang Jolly Pharma | CNE100001096 | 7.93 | 17.23 | -3.04% | |
Hunan Fangsheng Pharm | CNE100001VG6 | 7.83 | 10.67 | -4.05% | |
Mabwell Shanghai Bioscience | CNE100005RD2 | 6.98 | 28.58 | -3.35% | |
Ningbo Sanxing Medical Electric | CNE100001567 | 5.08 | 22.34 | +0.18% | |
Xiamen Amoytop Biotech Co | CNE100003RT3 | 4.78 | 72.48 | -1.16% | |
Beijing New Oriental Star Petro Eng | CNE100001X92 | 4.65 | 18.75 | -1.47% | |
InventisBio | CNE100005Q22 | 4.60 | 34.82 | -2.74% | |
Humanwell Healthcare | CNE000000QW6 | 4.57 | 21.20 | -2.44% | |
Runben Biotechnology | CNE100006DK5 | 4.56 | 35.89 | -3.08% | |
Shanghai Allist Pharmaceuticals Co | CNE100005XJ7 | 4.50 | 95.35 | -0.69% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Lord Value Advantage Stock Fund | 1.78B | -1.22 | -11.48 | 3.87 | ||
LACAM China Cyclical Strategy Equit | 681.24M | -2.79 | -10.82 | 3.06 | ||
Lord Growth Advantage Stock Fund | 185.6M | -1.62 | -7.86 | 1.65 | ||
Lord Theme Dynamic Asset Allocation | 10M | 3.29 | -6.91 | -0.52 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review